Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Feasibility and clinical relevance of HIV-1 drug resistance testing in patients with low-level viraemia in South Africa.

The Journal of antimicrobial chemotherapy - 15 Sept 2021

Bangalee Avania, Hans Lucia, Steegen Kim

Abstract excerpt

OBJECTIVES: To determine the feasibility of HIV genotyping at low-level viraemia (LLV) using an in-house assay in a South African population and the prevalence, as well as the clinical relevance, of drug resistance (HIVDR) in this population. METHODS: We conducted an observational, retrospective, cohort study on patient samples with LLV referred for routine HIVDR testing at a public sector Johannesburg laboratory...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Feasibility Studies

Share to HIV Infections

Share to South Africa

Share to Viral Load

Share to Viremia

Source

Identifiers

PMID: 34278422
DOI: 10.1093/jac/dkab220

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Feasibility and clinical relevance of HIV-1 drug resistance testing in patients with low-level viraemia in South Africa.PMID 34278422Read ↗

Reliability and Clinical Relevance of the HIV-1 Drug Resistance Test in Patients With Low Viremia LevelsSemantic proximity Read ↗

High Levels of Pretreatment HIV-1 Drug Resistance Mutations Among South African Women Who Acquired HIV During a Prospective Study.Semantic proximity Read ↗

Prevalence of drug resistance mutations in HIV-infected individuals with low-level viraemia under combination antiretroviral therapy: an observational study in a tertiary hospital in Northern Taiwan, 2017-19.Semantic proximity Read ↗

Characterization of drug resistance mutations in people living with HIV with low-level viremia on antiretroviral therapy in Chongqing, China.Semantic proximity Read ↗

Moderate Levels of Pre-Treatment HIV-1 Antiretroviral Drug Resistance Detected in the First South African National Survey.Semantic proximity Read ↗

HIV-1 Genotypic Resistance Testing Using Sanger and Next-Generation Sequencing in Adults with Low-Level Viremia in ChinaSemantic proximity Read ↗

Moderate-to-High Levels of Pretreatment HIV Drug Resistance in KwaZulu-Natal Province, South AfricaSemantic proximity Read ↗

The role of drug resistance in poor viral suppression in rural South Africa: findings from a population-based study.Semantic proximity Read ↗

HIV-1 drug resistance and resistance testing.Semantic proximity Read ↗

Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society–USA PanelSemantic proximity Read ↗

High level of HIV-1 drug resistance mutations in patients with unsuppressed viral loads in rural northern South AfricaSemantic proximity Read ↗

HIV-1 drug resistance mutations among individuals with low-level viraemia while taking combination ART in Botswana.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.